Panadol Cold and Flu Extra

Quick links

Choose a section

Quick links to important sections

Advertisements

Panadol Cold and Flu Extra

Advertisements

Treatment option:

Advertisements

Overview of Panadol Cold and Flu Extra

Property Description
Active ingredients Six-component mixture (Acetaminophen, Caffeine, Noscapine, Phenylephrine, Terpin Hydrate, Ascorbic Acid)
Form Oral tablet (Fixed-dose combination)
Pharmacological class Multi-symptom cold and flu relief agent
General purpose Concurrent relief from systemic and respiratory symptoms
Origin Primarily synthetic and semi-synthetic

Defining Panadol Cold and Flu Extra: A Multi-Component FDC Preparation

Panadol Cold and Flu Extra is classified as an Oral tablet belonging to the high-level pharmacological class of Multi-symptom cold and flu relief agents. It is a Fixed-dose combination (FDC) product, meaning it integrates several active ingredients into a singular preparation to provide concurrent management of various symptoms. This strategic composition is distinct from using separate, single-entity medications for isolated issues like pain or nasal congestion, aiming instead for comprehensive relief through one route of administration. The strategic rationale behind such multi-ingredient FDCs is their role in addressing the diversity of symptoms typical of upper respiratory tract infections.

What Active Ingredients Comprise This Synergistic Formula?

The functional core of the preparation is its synergistic mixture of six distinct active ingredients: Acetaminophen, Caffeine, Noscapine, Phenylephrine, Terpin Hydrate, and Ascorbic Acid (Vitamin C). Acetaminophen (Paracetamol) is included for its established role as a non-opioid analgesic and antipyretic agent for treating pain and fever. Phenylephrine is classified as an alpha-1 adrenergic agonist, which functions as a nasal decongestant. The formula's comprehensiveness is a key differentiating factor, featuring the antitussive properties of Noscapine alongside the expectorant action of Terpin Hydrate, a specialized combination not found in all standard cold relief medicines.

What is the General Therapeutic Purpose of the Formulation?

The general therapeutic purpose of the formulation is the symptomatic treatment of the collective discomforts associated with the common cold and influenza episodes, offering relief for adults and adolescents who experience multiple symptoms concurrently. This is achieved through the six components' combined actions, which include reducing fever and body aches via antipyresis and analgesia, alleviating nasal blockage, suppressing the cough reflex, and supporting the clearing of bronchial secretions. This approach is recognized for its ability to provide effective support during the acute phase of illness, helping to diminish the overall subjective burden of discomfort and fatigue associated with systemic viral infection.

Regulatory References

  1. MedlinePlus, Combination medicines for cold and flu
Advertisements

What side effects are possible with Panadol Cold and Flu Extra?

Possible Side Effects and Safety Information

The safety profile for this multi-component combination product is formally derived from the regulatory documentation of its active ingredients, including Acetaminophen, Phenylephrine, and Caffeine. Adverse reactions are classified by frequency and system-organ class as defined in official regulatory documents.

Regulatory Classification of Adverse Reactions

Adverse effects listed in official labeling are commonly grouped by the physiological system affected. Those most frequently classified as Common include effects on the nervous system, such as restlessness, insomnia, and mild headache, alongside cardiovascular effects like palpitations and increases in blood pressure (hypertension), primarily attributable to Phenylephrine and Caffeine.

Less frequently, or Rarely, documented effects include hematological abnormalities (blood dyscrasias like thrombocytopenia) and certain serious dermatological reactions.

Serious Adverse Reactions and Safety Constraints

Official regulatory sources specifically note the potential for severe hepatic failure, which is a documented risk associated with excessive intake or overdose of the Acetaminophen component. Serious skin reactions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are also explicitly listed in regulatory safety warnings.

Safety constraints necessitate specific considerations for certain patient populations. The product is officially contraindicated in individuals with severe hepatic insufficiency and in those with pre-existing severe cardiovascular conditions (e.g., severe hypertension or coronary artery disease) due to the presence of Phenylephrine. The label also specifies a strict maximum daily dose of Acetaminophen, a regulatory limitation intended to mitigate the risk of severe hepatotoxicity.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Overdose with this multi-component preparation poses risks primarily related to the combined toxicity of Acetaminophen, Caffeine, and Phenylephrine. Urgent hospital referral is essential and immediate medical attention must be sought for any suspected overdose, regardless of initial symptoms, as mandated by regulatory authorities. Contacting a Poison Control Center or emergency services immediately is required.

The primary severe risk is Liver Failure due to the Acetaminophen component, which may be preceded by non-specific manifestations such as nausea, vomiting, pallor, and abdominal pain. This risk necessitates the time-critical administration of the specific antidote, N-acetylcysteine (NAC), as outlined in official labeling. Population-specific considerations apply to staggered overdose scenarios.

Acute manifestations from the sympathomimetic components include documented Hypertensive Crisis, Tachycardia, Tremor, and severe neurological effects such as Seizures and Coma. Life-threatening outcomes include Ventricular Arrhythmia and Metabolic Acidosis. Continuous monitoring of Hepatic, Renal, and Cardiac function is required during hospital observation, along with laboratory assessment of Plasma Paracetamol Concentration to guide supportive management measures.

Advertisements

Therapeutic Uses of Panadol Cold and Flu Extra

What Panadol Cold and Flu Extra Treats: Main Uses and Benefits

The primary role of this multi-component preparation is to provide symptomatic relief for the common cold and influenza episodes, which are conditions characterized by periods of heightened symptoms. Managing these symptoms often involves the use of over-the-counter medicines to help ease discomfort. This product may be part of symptomatic management in scenarios involving acute symptom patterns.


This formulation is commonly used across conditions presenting with acute episodes that cause systemic and respiratory distress. It is relevant for easing headache, general body aches, and elevated body temperature (fever), alongside managing nasal congestion, sinus fullness, and the irritating cough reflex.

Quick Fact: Relief for Clustered Symptoms The multi-component nature helps address symptom clusters that may become intense, which is often the case when patients simultaneously experience pain, fever, and congestion during a seasonal illness.

This comprehensive approach contributes to improved comfort during periods of heightened symptoms. It is applied when patients seek supportive symptomatic assistance to manage disruptive manifestations, helpful in situations where multiple symptoms occur together. This product supports the patient during difficult episodes, which may assist with easing distress from clustered symptoms.

“It is commonly used across conditions presenting with acute episodes that cause systemic and respiratory distress.”

Regulatory References

  1. NHS guidance on cold and flu treatment
Advertisements

Eligibility and Restrictions for Use

Official Regulatory Eligibility and Restrictions

This section outlines the officially documented population eligibility and restrictions for this medicine, as defined by government regulatory agencies.

Eligibility Scope Status Affected Population
Absolute Contraindications Prohibited Individuals with known hypersensitivity to any component, severe hepatic impairment, or severe coronary artery disease. Use is strictly prohibited for those currently taking, or who have taken, a Monoamine Oxidase Inhibitor (MAOI) within the preceding 14 days.
Age-Based Eligibility Allowed Adults and adolescents aged 12 years and over.
Prohibited Children under 12 years of age are not recommended to use this medicine.
Conditional Use (Caution Advised) Restricted Populations with non-severe renal or hepatic impairment, non-severe hypertension, heart disease, diabetes mellitus, hyperthyroidism, glaucoma, or prostatic hypertrophy. Caution is also advised for chronic alcohol users.
Reproductive Health Status Not Recommended Use during pregnancy or breastfeeding is not recommended without seeking the advice of a health professional, as stated in the product labeling.

The official eligibility profile establishes clear boundaries, formally excluding populations with certain severe cardiovascular or hepatic conditions and those on specific concurrent medications. It permits use only in adults and adolescents 12 years or older, while formally restricting use in groups with numerous pre-existing conditions where heightened caution is required.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents describe a profile of interactions for this multi-component preparation, primarily concerning its active ingredients: Acetaminophen, Phenylephrine, and Noscapine.

Classification Interacting Agents Official Restriction or Constraint
Contraindicated Monoamine Oxidase Inhibitors (MAOIs) Strict prohibition on co-administration or within 14 days of cessation due to the risk of hypertensive crisis (Phenylephrine) and potentially fatal effects (Noscapine).
Pharmacodynamic Oral Anticoagulants (e.g., Warfarin) Prolonged regular daily use may potentiate the hypoprothrombinemic effect, increasing the International Normalized Ratio (INR).
Pharmacodynamic Other Sympathomimetic Agents Risk of additive pressor effects (increase in blood pressure) from Phenylephrine.
Pharmacokinetic Hepatic Microsomal Enzyme Inducers Co-use with agents like certain anticonvulsants may increase the documented risk of Acetaminophen toxicity.

Other Documented Interactions

Substances that increase gastric emptying (e.g., Metoclopramide) will accelerate Acetaminophen absorption. Conversely, Cholestyramine reduces absorption if administered within one hour of the dose. Phenylephrine may reduce the efficacy of certain antihypertensive drugs (e.g., alpha- and beta-blockers). Caution is advised regarding potential enhanced CNS depression when Noscapine is co-administered with centrally sedating substances. Furthermore, chronic excessive alcohol consumption is documented as a risk factor that increases the likelihood of Acetaminophen-related liver damage.

Advertisements

Mechanism of Action

Central Neuro-modulation of Thermal and Pain Signaling

This domain involves Acetaminophen and Noscapine, which modulate CNS pathways. Acetaminophen acts as an inhibitor of Cyclooxygenase enzymes in the hypothalamus, decreasing PGE2 synthesis to alter the body’s thermal set-point and modulating central nociceptive signaling. Noscapine modifies the Sigma-1 receptor in the brainstem to elevate the cough reflex threshold. This results in altered thermal control and modification of central reflex thresholds.

Autonomic Control of Vascular Tone and Secretions

This peripheral domain utilizes Phenylephrine and Terpin Hydrate to regulate local tissue responses. Phenylephrine acts as an alpha1 agonist on nasal venules, inducing vasoconstriction that results in the physical decrease of vascular volume in the tissue. Terpin Hydrate stimulates bronchial secretory glands, increasing the fluidity of secretions. These actions result in the modulation of peripheral vascular tone and altered secretory output.

Purinergic System Antagonism and Central Pathway Modification

Caffeine engages in competitive antagonism of inhibitory Adenosine Receptors ( A1/ A2A) throughout the CNS. This mechanism blocks inhibitory signaling, leading to secondary increases in neuronal activity and altered CNS excitability. Critically, this antagonism modifies the central pathway used by Acetaminophen via A1/ A2A receptor blockade, influencing the nociceptive signaling cascade.

Mechanistic Constraints and Cofactor Involvement

The action is mechanistically constrained by Acetaminophen's weak peripheral COX inhibition, restricting its influence on peripheral inflammatory pathways. Ascorbic Acid is present due to its antioxidant role and involvement as an enzyme cofactor in metabolic pathways, but its mechanism does not directly influence core thermal, nociceptive, or vascular pathways.

Advertisements

Dosage and Administration Information

Panadol Cold and Flu Extra is administered exclusively via the oral route as a solid caplet dosage form. The general principle of administration involves swallowing the caplet whole with fluid. This medicine is approved for use in adults and adolescents aged 12 years and over.

The standard single adult dose is established as two caplets, which may be taken when necessary for symptom management. The frequency of administration is procedurally constrained by a mandatory minimum interval: the dose must not be repeated more frequently than every four hours (q4 h). This minimum time separation is critical to ensure appropriate dosing.

The maximum daily intake is an absolute procedural constraint. Adults and adolescents aged 16 years and over must not exceed eight caplets in any 24-hour period. This maximum dose corresponds to the established 4000 mg daily limit for immediate-release oral acetaminophen. A more restricted maximum of four tablets in 24 hours is typically applied to adolescents aged 12 to 15 years. The overall use pattern is restricted to short-term symptomatic management only. If a dose is missed, it can be taken when remembered, provided the necessary four-hour interval is preserved before the next administration.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Panadol Cold and Flu Extra


Evidence for Symptomatic Relief of Clustered Cold and Flu Symptoms

Clinical research has focused on Fixed-Dose Combinations (FDCs) like this one, which were studied for their use in managing several symptoms typical of a cold or flu episode at the same time. These studies primarily take the form of short-term Randomized Controlled Trials (RCTs) and subsequent Systematic Reviews that evaluate the combination approach. Research examined symptoms that are relevant in evidence describing how symptoms are measured, such as pain, fever, and congestion. The primary outcomes used in these trials are typically Total Symptom Scores, which are composite measurements used in research exploring how symptoms change over time.

These studies were conducted during periods of increased symptom activity, primarily including otherwise healthy Adults and Adolescents experiencing acute, uncomplicated illness. Studies observed how symptoms evolved in the observed populations, and research reports measurements related to changes in the Total Symptom Scores when compared to a placebo over the short study duration. Comparative evidence is lacking specifically for this six-component formulation against all other available FDCs.


Evidence for Relief of Pain and Fever (Analgesic and Antipyretic Component)

The research base for the pain and fever-reducing component (Acetaminophen) is substantial. The function of this component was studied for outcomes related to systemic or functional imbalance, specifically fever and pain, in numerous systematic reviews and RCTs. The findings from this body of research describe the observed symptom evolution in the populations studied, with reports indicating that the component was associated with measurements of objective temperature reduction and pain intensity changes.

However, the majority of this high-level evidence describes group patterns based on the component studied alone or in simple combinations. The precise contribution of this specific single component to the overall relief within this six-ingredient formulation is less defined than its role as a stand-alone agent.


Evidence for Relief of Nasal Congestion (Decongestant Component)

The research concerning the oral decongestant component (Phenylephrine) was evaluated in trials aiming to measure its effect on outcomes linked to inflammatory or irritative states, such as nasal blockage. Findings were mixed across systematic reviews; while some studies monitored patterns related to subjective patient-reported experiences, objective measurements in certain trials reported findings that did not differ significantly from placebo at the standard doses used. The certainty remains low regarding the consistency of observed outcomes for the oral decongestant component at the dose contained in this product.


What is Still Uncertain About the Research

The follow-up durations for combination product trials were typically short (48 to 72 hours), meaning long-term effects are not fully established for this medication. Furthermore, data for certain groups, such as older adults with flu-like symptoms or individuals with pre-existing, non-respiratory chronic health conditions, remain insufficient. The existing research provides context but not individual predictions about the response for people in these less-studied groups.

Key Studies & References

  1. Fixed-dose combination drugs versus single-ingredient preparations for treating symptomatic common cold and flu: a systematic review and meta-analysis
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Panadol Cold and Flu Extra (FAQ)

Q: Is Panadol Cold and Flu Extra the same as regular Panadol?

No. Regulatory documents state that regular Panadol usually contains only the active ingredient acetaminophen (paracetamol). Panadol Cold and Flu Extra is a Fixed-Dose Combination (FDC) that contains acetaminophen plus several other active ingredients for multi-symptom relief.

Q: Can Panadol Cold and Flu Extra make you feel sleepy?

Official drug information states that side effects may include dizziness or drowsiness for some formulations. However, the product contains stimulating ingredients, and other commonly reported effects in regulatory documents include restlessness and insomnia.

Q: How long does it typically take to feel the effect of Panadol Cold and Flu Extra?

Pharmacokinetic studies on the main analgesic component (paracetamol) indicate that it is absorbed rapidly. Peak plasma concentrations for the component are typically reached within 10 to 60 minutes after oral administration.

Q: What is the expected duration of the effects from one dose?

The official minimum interval between doses is set at four hours, which informs the expected duration of effect. While the half-life for the pain-relieving component is typically short, the half-life for all six active ingredients varies.

Q: Is it acceptable to drink coffee or caffeine while using Panadol Cold and Flu Extra?

This medicine contains caffeine as an active ingredient. Taking external caffeine (such as coffee) concurrently may enhance stimulant-related side effects, including increased heart rate or blood pressure, as indicated in official warnings.

Q: What happens if I accidentally take a tablet close to bedtime?

Due to the presence of stimulating active ingredients, common side effects can include restlessness and insomnia. Taking the caplets close to bedtime may increase the risk of experiencing these stimulating effects, which could make falling asleep difficult.

Q: Is Panadol Cold and Flu Extra gluten-free or lactose-free?

The official product information includes a full list of inactive ingredients, or excipients. Official guidelines state that checking the product label or official product information is required to verify the presence of all components.

Q: Does using this medicine affect the results of any common medical tests?

Regulatory documents state that the active ingredient acetaminophen may interfere with the results of certain laboratory tests. This interference has been documented particularly with some blood glucose tests.

Q: Do I need to eat food before or after taking Panadol Cold and Flu Extra?

Official administration guidelines advise swallowing the caplet whole with fluid. Drug labels do not typically require the medicine to be taken with food, though studies indicate that the absorption of the pain-relieving component can be affected by food intake.

Q: Can Panadol Cold and Flu Extra cause stomach upset or nausea?

Yes, regulatory documentation indicates that gastrointestinal effects like nausea and vomiting are commonly or very commonly reported side effects in combination products containing acetaminophen.

Q: Is this product considered a non-drowsy formulation?

Some versions of Panadol Cold and Flu, specifically those without sedating antihistamines, are officially marketed by the manufacturer as 'Non-Drowsy' formulations.

Q: What is the purpose of the 'Extra' designation in the product name?

The 'Extra' designation is generally used to indicate that the product contains more than one active component, setting it apart from single-ingredient pain relief products.

Q: Are there specific symptoms that indicate this medicine is not appropriate to treat?

Official product information describes certain severe reactions, such as sudden severe headache or unexplained bleeding, which indicate that the use should be discontinued and medical assessment sought.

Q: Can this product be taken alongside antibiotics?

Regulatory safety statements indicate the paracetamol component has been studied for co-administration with many antibiotics. However, official product labels provide warnings regarding specific interactions, particularly with chloramphenicol or flucloxacillin.

Q: What is the guidance on driving or operating machinery while using this medicine?

Official regulatory advice cautions patients against driving or operating machinery. This restriction applies if they are experiencing side effects such as drowsiness or dizziness.

Q: Can Panadol Cold and Flu Extra be used for a fever that is not related to a cold or flu?

The therapeutic indication for this fixed-dose combination product is the symptomatic treatment of the collective discomforts of the common cold and flu. While the paracetamol component can reduce fever, the primary approved purpose is for multi-symptom relief associated with cold or flu.

Q: Are there any known issues with taking Panadol Cold and Flu Extra if I have high blood pressure?

Yes. Regulatory documents state the medicine is strictly contraindicated in patients with severe hypertension or severe coronary artery disease. Caution is advised for those with non-severe hypertension due to the phenylephrine component.

Q: What common over-the-counter medicines should be checked for interactions before using this product?

Official regulatory interaction warnings advise checking for products containing acetaminophen (paracetamol) and any sympathomimetic agents, such as other decongestants.

Q: Are there any specific food items or beverages that might interfere with this medicine?

Yes. Official warnings note that chronic excessive alcohol consumption is a specific risk factor. This increases the likelihood of acetaminophen-related liver damage.

Q: Why is it noted that the medicine should not be used for more than a few days?

The restriction to short-term use is necessary for two main reasons stated in official documents. First, it is required to mitigate the risk of exceeding the maximum recommended daily dose (which can cause liver damage). Second, it ensures that prolonged symptoms, which may indicate a more serious underlying condition, do not go unaddressed.

Q: Is it possible to experience dizziness or nervousness after taking this medicine?

Yes. Regulatory documents classify side effects like dizziness, nervousness, and restlessness as common or possible. These effects are primarily associated with the presence of phenylephrine and caffeine.

Q: Are there restrictions on how much alcohol someone can consume while using Panadol Cold and Flu Extra?

Official warnings state that chronic excessive alcohol consumption is a risk factor for liver damage related to the acetaminophen component. Some regulatory labels cite consumption of three or more alcoholic drinks every day as a specific risk threshold.

Q: What specific instructions are given regarding concurrent use of antidepressant medications?

Regulatory documents provide a strict contraindication regarding Monoamine Oxidase Inhibitors (MAOIs), a class of antidepressant. The medicine is strictly prohibited for use with, or within 14 days of stopping, an MAOI due to the risk of severe reactions.

Q: Is there a maximum number of days regulatory documents suggest using this medicine consecutively?

Regulatory patient information generally advises taking the medication for a maximum of three to five days. Symptoms persisting or worsening after this period should be assessed by a healthcare professional.

Q: What happens if a user is allergic to one of the inactive ingredients?

Official warnings specify that the medicine is strictly contraindicated if a person has a known hypersensitivity or allergy to acetaminophen or any of the inactive ingredients contained in the product.

Q: Is the evidence for this drug combination based on large-scale clinical trials?

Regulatory overviews state that the product’s claims are supported by evidence from short-term Randomized Controlled Trials (RCTs) and systematic reviews focused on Fixed-Dose Combinations (FDCs).

Advertisements

How should Panadol Cold and Flu Extra be stored and disposed of?

Official Storage and Disposal Requirements

Panadol Cold and Flu Extra must be stored strictly according to the conditions detailed in official regulatory documentation to maintain its stability and effectiveness.

Condition Type Requirement Summary
Temperature Store below 30 C (or 25 C for some formulations).
Environment Keep the medicine in a cool, dry place, protected from moisture and direct light. Do not store in prohibited areas like the bathroom, near a sink, on a window sill, or in a car.
Child Safety Keep out of the sight and reach of children at all times.
Stability Do not use the medicine after the expiry date printed on the original package.
Disposal Return unused or expired medication to a pharmacist through an authorized drug take-back program. If a program is unavailable, mix the medicine with an unappealing substance (e.g., dirt) in a sealed bag or container, and place it in household trash. Scratch out personal information on packaging before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Panadol Cold and Flu Extra found in:

A-Z Index: